Načítá se...
Histone Deacetylase (HDAC) Inhibition as a Novel Treatment for Diabetes Mellitus
Both common forms of diabetes have an inflammatory pathogenesis in which immune and metabolic factors converge on interleukin-1β as a key mediator of insulin resistance and β-cell failure. In addition to improving insulin resistance and preventing β-cell inflammatory damage, there is evidence of gen...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
ScholarOne
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3105132/ https://ncbi.nlm.nih.gov/pubmed/21274504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00021 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|